Amphastar Pharmaceuticals EPS - Earnings per Share 2012-2024 | AMPH

Amphastar Pharmaceuticals eps - earnings per share from 2012 to 2024. Eps - earnings per share can be defined as a company's net earnings or losses attributable to common shareholders per diluted share base, which includes all convertible securities and debt, options and warrants.
Amphastar Pharmaceuticals Annual EPS
2023 $2.60
2022 $1.74
2021 $1.25
2020 $0.03
2019 $0.98
2018 $-0.12
2017 $0.08
2016 $0.21
2015 $-0.06
2014 $-0.25
2013 $0.31
2012 $0.46
2011 $0.20
2009 $0.00
Amphastar Pharmaceuticals Quarterly EPS
2024-09-30 $0.78
2024-06-30 $0.73
2024-03-31 $0.81
2023-12-31 $0.70
2023-09-30 $0.91
2023-06-30 $0.49
2023-03-31 $0.50
2022-12-31 $0.64
2022-09-30 $0.30
2022-06-30 $0.33
2022-03-31 $0.47
2021-12-31 $0.40
2021-09-30 $0.59
2021-06-30 $0.16
2021-03-31 $0.10
2020-12-31 $-0.13
2020-09-30 $0.08
2020-06-30 $0.00
2020-03-31 $0.08
2019-12-31 $-0.03
2019-09-30 $0.03
2019-06-30 $0.96
2019-03-31 $0.02
2018-12-31 $0.04
2018-09-30 $0.05
2018-06-30 $-0.06
2018-03-31 $-0.15
2017-12-31 $0.02
2017-09-30 $0.00
2017-06-30 $0.04
2017-03-31 $0.02
2016-12-31 $-0.07
2016-09-30 $0.08
2016-06-30 $0.15
2016-03-31 $0.05
2015-12-31 $0.17
2015-09-30 $-0.07
2015-06-30 $-0.15
2015-03-31 $-0.01
2014-12-31 $-0.06
2014-09-30 $-0.12
2014-06-30 $-0.03
2014-03-31 $-0.04
2013-12-31 $0.05
2013-09-30 $0.00
2013-06-30 $0.20
2013-03-31 $0.06
2012-12-31 $0.11
2012-09-30 $0.08
2012-06-30 $0.13
2012-03-31 $0.14
2011-12-31 $0.00
Sector Industry Market Cap Revenue
Medical Medical - Generic Drugs $2.186B $0.644B
Amphastar Pharmaceuticals, Inc. is a specialty pharmaceutical company. It focuses primarily on developing, manufacturing, marketing, and selling generic and proprietary injectable and inhalation products. The company products include Enoxaparin Sodium Injection; Amphadase; Cortrosyn for Injection; and prefilled disposable emergency syringes for crash cart use. Amphastar Pharmaceuticals, Inc. is headquartered in Rancho Cucamonga, California.
Stock Name Country Market Cap PE Ratio
Teva Pharmaceutical Industries (TEVA) Israel $19.395B 6.36
Dr Reddy's Laboratories (RDY) India $11.853B 22.68
BridgeBio Pharma (BBIO) United States $4.426B 0.00
Bausch Health Cos (BHC) Canada $2.931B 2.13
Supernus Pharmaceuticals (SUPN) United States $2.000B 27.23
Taysha Gene Therapies (TSHA) United States $0.506B 35.29
Personalis (PSNL) United States $0.245B 0.00
Assembly Biosciences (ASMB) United States $0.096B 0.00
Sol-Gel Technologies (SLGL) Israel $0.015B 0.00
Evoke Pharma (EVOK) United States $0.006B 0.00
Teligent (TLGT) United States $0.000B 0.00